Posted in Uncategorized Novavax, Moderna Stocks May Not Get Boost From Next Phase of Covid-19 … November 20, 2022 Moderna, Novavax, BioNTech, and Pfizer shares are all in the red so far in 2022. Updated vaccines may not have an effect on the share prices. https://www.barrons.com/articles/covid-vaccines-stocks-51654706194